Beigene Ltd
SSE:688235

Watchlist Manager
Beigene Ltd Logo
Beigene Ltd
SSE:688235
Watchlist
Price: 164 CNY 0.99% Market Closed
Market Cap: 146.3B CNY
Have any thoughts about
Beigene Ltd?
Write Note

EV/FCFF
Enterprise Value to FCFF

-16.5
Current
-8.4
Median
4.1
Industry
Lower than median
Lower than industry value

Enterprise Value to Free Cash Flow To Firm (EV/FCFF) ratio is a valuation multiple that compares the value of a company, debt included, to the amount of free cash flow available for all stakeholders. This metric is very similar to the EV/OCF but is considered a more exact measure, owing to the fact that it uses free cash flow, which subtracts capital expenditures (CapEx) from a company's operating cash flow.

EV/FCFF
-16.5
=
Enterprise Value
135.1B CNY
/
FCFF
-8.2B CNY
All Countries
Close
Market Cap EV/FCFF
KY
Beigene Ltd
SSE:688235
146.3B CNY -16.5
FR
Pharnext SCA
OTC:PNEXF
6T USD -238 568.4
US
Abbvie Inc
NYSE:ABBV
315.8B USD 23.5
US
Amgen Inc
NASDAQ:AMGN
141.1B USD 30.1
US
Gilead Sciences Inc
NASDAQ:GILD
117.2B USD 11.2
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
105.3B USD -72.2
US
Epizyme Inc
F:EPE
94.1B EUR -470.2
AU
CSL Ltd
ASX:CSL
136.4B AUD 62.8
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
78.7B USD 21.6
US
Seagen Inc
F:SGT
39.3B EUR -56.7
NL
argenx SE
XBRU:ARGX
36.2B EUR -106.4
 
KY
Beigene Ltd
SSE:688235
Average EV/FCFF: 29.8
Negative Multiple: -16.5
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -238 568.4
US
Abbvie Inc
NYSE:ABBV
23.5
US
Amgen Inc
NASDAQ:AMGN
30.1
US
Gilead Sciences Inc
NASDAQ:GILD
11.2
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Negative Multiple: -72.2
US
E
Epizyme Inc
F:EPE
Negative Multiple: -470.2
AU
CSL Ltd
ASX:CSL
62.8
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
21.6
US
S
Seagen Inc
F:SGT
Negative Multiple: -56.7
NL
argenx SE
XBRU:ARGX
Negative Multiple: -106.4

EV/FCFF Forward Multiples

Forward EV/FCFF multiple is a version of the EV/FCFF ratio that uses forecasted free cash flow to firm for the EV/FCFF calculation. 1-Year, 2-Years, and 3-Years forwards use free cash flow to firm forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
EV/FCFF
N/A
2-Years Forward
EV/FCFF
N/A
3-Years Forward
EV/FCFF
N/A

See Also

Discover More